Literature DB >> 501287

Tumorigenicity of Indian muntjac diploid cells by the proviral integration of sarcoma gene of a mouse retrovirus.

M Hatanaka, R Klein.   

Abstract

The transformed clonal isolates of Indian muntjac diploid cells by a mouse sarcoma virus, 43-2XV, were tested for tumorigenicity in athymic nude mice. In spite of the indistinguishable transformed morphology, the tumorigenicity exhibited four different patterns: (a) no tumor formation; (b) slowly growing regressive tumor formation; (c) rapidly growing regressive tumor formation; and (d) rapidly growing progressive tumor formation. This demonstrates that the same diploid host cells transformed by the same virus reveal variable patterns of tumorigenic expression and some transformed host cells lack the tumorigenicity entirely. The findings that there are at least two chromosomes and four recombinant sites assigned for the proviral integrations of the sarcoma gene into the Indian muntjac gene (M. Hatanaka, R. Klein, R. Kominami, T. Oikawa, H. Okabe, N. Tsuchida, E. C. Connors, and A. Carrano. Transformation of Indian muntjac diploid cells by the proviral integration of sarcoma gene of a mouse retrovirus. Manuscript in preparation.) lead us to propose a hypothesis that variable expressions of tumorigenicity under the neutral background of immune responses, may arise from variable integrations of the sarcoma gene into the host chromosome.

Entities:  

Mesh:

Year:  1979        PMID: 501287      PMCID: PMC2185692          DOI: 10.1084/jem.150.5.1195

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  In vitro correlates of transformation in C3H/10T1/2 clone 8 mouse cells.

Authors:  P A Jones; W E Laug; A Gardner; C A Nye; L M Fink; W F Benedict
Journal:  Cancer Res       Date:  1976-08       Impact factor: 12.701

2.  Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice.

Authors:  C O Povlsen; P J Fialkow; E Klein; G Klein; J Rygaard; F Wiener
Journal:  Int J Cancer       Date:  1973-01-15       Impact factor: 7.396

3.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.

Authors:  V H Freedman; S I Shin
Journal:  Cell       Date:  1974-12       Impact factor: 41.582

4.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

5.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

Authors:  S I Shin; V H Freedman; R Risser; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

6.  Failure of human cells transformed by simian virus 40 to form tumors in athymic nude mice.

Authors:  C D Stiles; W Desmond; G Sato; M H Saier
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

7.  Sarcoma and helper-specific RNA tumor virus subunits in transformed nonproducer mouse cells activated to produce virus by treatment with bromodeoxyuridine.

Authors:  N Tsuchida; M S Shih; R V Gilden; M Hatanaka
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

8.  Mutants of nonproducer cell lines transformed by murine sarcoma virus. II. Relationship of tumorigenicity to presence of viral markers and rescuable sarcoma genome.

Authors:  M Hatanaka; R Klein; C W Lomg; R Gilden
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

9.  Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity.

Authors:  M Hatanaka; R Klein; R Toni; J Walker; R Gilden
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

10.  Mutants of nonproducer cell lines transformed by murine sarcoma virus. 3. Detection and characterization of RNA specific for helper and sarcoma viruses.

Authors:  N Tsuchida; M Shih; R V Gilden; M Hatanaka
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.